CYBN – cybin inc. common shares (US:NASDAQ)
Stock Stats
News
Cybin (OTCMKTS:CYBN) had its "buy" rating reaffirmed by analysts at Guggenheim.
Cybin Inc (CYBN) Q2 2026 Earnings Call Highlights: Strategic Advancements Amid Financial Challenges [Yahoo! Finance]
Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $70.00 to $45.00. They now have a "buy" rating on the stock.
Cybin (OTCMKTS:CYBN) had its price target lowered by analysts at HC Wainwright from $150.00 to $55.00. They now have a "buy" rating on the stock.
Fibroblast Growth Factors Market Global Forecast Report 2025-2030: Opportunities in Regenerative Medicine, Oncology, and Metabolic Disorders Due to Advances in Molecular Biology, Delivery Technologies [Yahoo! Finance]
Form 6-K CYBIN INC. For: Nov 26
Form D CYBIN INC.
Form SCHEDULE 13G/A CYBIN INC. Filed by: Point72 Asset Management, L.P.
Form 6-K CYBIN INC. For: Nov 13
Form 6-K CYBIN INC. For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.